Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dna X (SONM) Share-based Compensation (2018 - 2025)

Dna X filings provide 8 years of Share-based Compensation readings, the most recent being $159000.0 for Q4 2025.

  • On a quarterly basis, Share-based Compensation fell 55.34% to $159000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $1.5 million, a 1.05% increase, with the full-year FY2025 number at $1.5 million, up 1.05% from a year prior.
  • Share-based Compensation hit $159000.0 in Q4 2025 for Dna X, down from $166000.0 in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $926000.0 in Q2 2025 to a low of -$650000.0 in Q4 2023.
  • Median Share-based Compensation over the past 5 years was $293000.0 (2021), compared with a mean of $242700.0.
  • Biggest five-year swings in Share-based Compensation: tumbled 291.38% in 2022 and later soared 194.55% in 2024.
  • Dna X's Share-based Compensation stood at $325000.0 in 2021, then tumbled by 291.38% to -$622000.0 in 2022, then fell by 4.5% to -$650000.0 in 2023, then soared by 154.77% to $356000.0 in 2024, then plummeted by 55.34% to $159000.0 in 2025.
  • The last three reported values for Share-based Compensation were $159000.0 (Q4 2025), $166000.0 (Q3 2025), and $926000.0 (Q2 2025) per Business Quant data.